Medical
Funding Moves at Optimi Health Show Confidence Within the Psychedelic Industry
Optimi Health Corp. (CSE: OPTI, OTCQX: OPTHF, FRA: 8BN), a Canadian manufacturer of pharmaceutical-grade MDMA and natural psilocybin, recently announced two key financial arrangements that...
Ascend Wellness Opens New Chapter with Revamped eCommerce and Loyalty Ecosystem
Ascend Wellness Holdings (CSE: AAWH.U, OTCQX: AAWH), known for its footprint across multiple states, has shifted the digital cannabis retail experience with the launch of...
HEALWELL Sharpens Its AI Focus With Full Pentavere Acquisition and Surging Revenue
HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) is making waves in the healthcare technology sector after sharing a glimpse into a robust 2025. The Canadian-based...
Medical City Dallas Hospital Integrates Advanced Tissue Imaging for Surgeries
Medical City Dallas Hospital has started using Perimeter Medical Imaging AI’s (OTCQX: PYNKF) S-Series OCT technology in its operating rooms, marking a new chapter in...
Maven Clinic and Oura Team Up to Bring Wearable Data to Virtual Women’s Health Care
Maven Clinic, recognized as the world’s largest virtual clinic focused on women’s and family health, is taking a significant step forward by partnering with Oura,...
The Shift Toward Gentler and More Effective Cancer Treatments
The pharmaceutical industry is in the midst of a significant shift as antibody-drug conjugates (ADCs) emerge as a promising alternative to traditional chemotherapy for cancer...
Endo Sells International Pharmaceuticals Business to Knight Therapeutics for $105 Million
Endo, Inc. (OTCQX: NDOI) has wrapped up the sale of its International Pharmaceuticals business, marking a significant shift in the company’s focus and portfolio. The...
Tonix Pharmaceuticals Advances New Non-Opioid Treatment for Fibromyalgia
Tonix Pharmaceuticals (NASDAQ: TNXP) is on the cusp of a potential breakthrough in fibromyalgia treatment with its investigational drug TNX-102 SL. The sublingual formulation of...
Thiogenesis Gets FDA Green Light for Phase 2a Leigh Syndrome Trial
Thiogenesis Therapeutics, Corp. (TSXV: TTI, OTCQX: TTIPF), a clinical-stage biopharmaceutical company based in San Diego, has received clearance from the U.S. Food and Drug Administration...
Paradromics Achieves First Human Implantation of Brain Computer Interface
Paradromics, a private neurotechnology company at the forefront of brain-computer interface (BCI) development, recently reached a significant milestone, its device was implanted in a human...
